Stockscreener 앱 받기
235.30
2.88%
6.4975
전일 마감가:
$228.80
열려 있는:
$225.71
하루 거래량:
1.08M
Relative Volume:
0.76
시가총액:
$33.71B
수익:
$2.50B
순이익/손실:
$-226.32M
주가수익비율:
-143.37
EPS:
-1.6412
순현금흐름:
$71.51M
1주 성능:
+6.94%
1개월 성능:
+15.85%
6개월 성능:
-0.00%
1년 성능:
+38.16%
1일 변동 폭
$224.35
$240.72
1주일 범위
$217.72
$240.72
52주 변동 폭
$131.81
$256.36
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
235.36 | 33.14B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
467.31 | 172.66B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
178.88 | 125.40B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
541.86 | 44.34B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
126.99 | 35.89B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
355.18 | 34.90B | 3.77B | 449.25M | 240.68M | 7.8556 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-14 | 개시 | William Blair | Outperform |
| 2026-01-07 | 개시 | Citigroup | Buy |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-27 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 재개 | Wells Fargo | Equal Weight |
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Natera (NTRA) Stock Fair Value Edges Lower As MRD And Signatera Debate Splits Analysts - Yahoo Finance
Why Is Natera Stock Gaining Tuesday? - Benzinga
Natera’s Signatera receives NCCN Category 1 recommendation By Investing.com - Investing.com Canada
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update - Business Wire
Natera co-founder Sheena Jonathan sells $329,809 in company stock - Investing.com UK
Signatera (NTRA) Gains Momentum with New NCCN Bladder Cancer Gui - GuruFocus
Form 4 Natera Inc For: 22 June By Investing.com - Investing.com Canada
Natera (NTRA) co-founder’s family trusts sell 1,500 shares under 10b5-1 plan - Stock Titan
Natera co-founder Sheena Jonathan sells $329,809 in company stock By Investing.com - Investing.com Canada
Natera expands Austin operations with new sequencing facility - MSN
Pirche Announces Partnership to Advance Transplant Medicine by Combining Pre-Transplant Risk Stratification and Post-Transplant dd-cfDNA Monitoring - marketscreener.com
Natera IVF Genetic Testing Class Action Lawsuit Claims PGT-A Results Were Misleading - AboutLawsuits.com
Natera (NTRA) Stock Could Be 11.3% Undervalued After Prospera Transplant Data - simplywall.st
Natera StockWeekly review and sector comparison after recent capital raise - AD HOC NEWS
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress - The National Law Review
Natera to present 21 transplant studies, including 7 oral talks - Stock Titan
Natera director Rowan Chapman sells $642,535 in stock By Investing.com - Investing.com Australia
Insider Sell: Rowan Chapman Sells 2,964 Shares of Natera Inc (NT - GuruFocus
Natera Inc (NTRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Natera co-founder Sheena Jonathan sells $665,087 in shares By Investing.com - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $665,087 in shares - Investing.com
Natera director Rowan Chapman sells $642,535 in stock - Investing.com
Natera (NTRA) co-founder Sheena Jonathan sells 3,150 shares in 10b5-1 plan trades - Stock Titan
Natera Inc (NTRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Natera Inc (NTRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Natera Inc (NTRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Natera Inc (NTRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Natera Inc (NTRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Natera Inc (NTRA) Institutional Confidence - TradingKey
Is Natera’s CytoDyn ctDNA Tie-Up and Board Refresh Reframing the Investment Case for NTRA? - simplywall.st
Natera (NTRA), CytoDyn Announce Strategic Collaboration for ctDNA-Guided mCRC Clinical Trials - Yahoo Finance
Natera executive chairman sells $21.4 million in shares By Investing.com - Investing.com South Africa
Natera executive chairman sells $21.4 million in shares - Investing.com
Executive chairman of Natera (NTRA) sells 100,000 shares in Rule 10b5-1 trades - Stock Titan
Natera shareholders approve equity plan amendment and elect directors at annual meeting - Investing.com UK
Thomas Lynch joins Natera (NASDAQ: NTRA) board as new independent director - Stock Titan
Natera (NASDAQ: NTRA) OKs equity plan share boost and director slate - Stock Titan
[144] Natera, Inc. SEC Filing - Stock Titan
Goldman Sachs Initiates Coverage on Natera, Inc. (NTRA) - Yahoo Finance
Natera, Inc. (NTRA) Stock Analysis: Evaluating a 22.62% Potential Upside in the Diagnostics Arena - DirectorsTalk Interviews
Billionaire Stanley Druckenmiller’s Top Bet: Natera (NTRA) and the Rise of Liquid Biopsy TestingMid-Term Outlook - newsline.com
Natera to launch enhanced Panorama NIPT for low fetal fractions - MSN
Natera Shares Slide Over 3% as Stock Tests Key Support LevelsCharm Flow - newsline.com
Forget SpaceX Hype: Billionaire Stanley Druckenmiller is Loading Up on This Unknown Healthcare Stock - Insider Monkey
Morgan Stanley files Form 144 for 100,000 NTRA shares (NASDAQ: NTRA) - Stock Titan
Natera Inc Stock (US6323071042): Analyst calls from RBC and Goldman put diagnostics specialist in fo - AD HOC NEWS
Natera MRD Leadership Supported by 'Durable' High-Value Market, RBC Says - Moomoo
NTRA & Diakonos partner to use Signatera in refractory melanoma trial - MSN
RBC Capital Maintains Natera(NTRA.US) With Buy Rating, Cuts Target Price to $275 - Moomoo
Natera stock jumps into focus as RBC resumes coverage with Outperform rating and a $275 price target - Business Upturn
RBC Capital initiates Natera stock coverage with outperform rating By Investing.com - Investing.com Australia
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Natera Inc 주식 (NTRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Chapman Rowan E | Director |
Jun 16 '26 |
Sale |
216.78 |
2,964 |
642,536 |
3,124 |
| Sheena Jonathan | CO-FOUNDER |
Jun 15 '26 |
Sale |
211.14 |
3,150 |
665,087 |
249,352 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Jun 15 '26 |
Sale |
214.91 |
50,000 |
10,745,662 |
2,277,843 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Jun 12 '26 |
Sale |
214.03 |
50,000 |
10,701,645 |
2,327,843 |
0.23%
0.55%
자본화:
|
볼륨(24시간):